GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Mezzion Pharma Co (XKRX:140410) » Definitions » Cyclically Adjusted PS Ratio

Mezzion Pharma Co (XKRX:140410) Cyclically Adjusted PS Ratio : 46.15 (As of May. 22, 2024)


View and export this data going back to 2012. Start your Free Trial

What is Mezzion Pharma Co Cyclically Adjusted PS Ratio?

As of today (2024-05-22), Mezzion Pharma Co's current share price is ₩37500.00. Mezzion Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 was ₩812.48. Mezzion Pharma Co's Cyclically Adjusted PS Ratio for today is 46.15.

The historical rank and industry rank for Mezzion Pharma Co's Cyclically Adjusted PS Ratio or its related term are showing as below:

XKRX:140410' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 18.07   Med: 45.03   Max: 116.87
Current: 46.59

During the past years, Mezzion Pharma Co's highest Cyclically Adjusted PS Ratio was 116.87. The lowest was 18.07. And the median was 45.03.

XKRX:140410's Cyclically Adjusted PS Ratio is ranked worse than
99.19% of 744 companies
in the Drug Manufacturers industry
Industry Median: 2.135 vs XKRX:140410: 46.59

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Mezzion Pharma Co's adjusted revenue per share data for the three months ended in Mar. 2024 was ₩72.877. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is ₩812.48 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Mezzion Pharma Co Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Mezzion Pharma Co's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mezzion Pharma Co Cyclically Adjusted PS Ratio Chart

Mezzion Pharma Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 111.72 18.21 48.33

Mezzion Pharma Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 21.98 48.75 52.58 48.33 48.68

Competitive Comparison of Mezzion Pharma Co's Cyclically Adjusted PS Ratio

For the Drug Manufacturers - General subindustry, Mezzion Pharma Co's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Mezzion Pharma Co's Cyclically Adjusted PS Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Mezzion Pharma Co's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Mezzion Pharma Co's Cyclically Adjusted PS Ratio falls into.



Mezzion Pharma Co Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Mezzion Pharma Co's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=37500.00/812.48
=46.15

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Mezzion Pharma Co's Cyclically Adjusted Revenue per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Mezzion Pharma Co's adjusted Revenue per Share data for the three months ended in Mar. 2024 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=72.877/118.8477*118.8477
=72.877

Current CPI (Mar. 2024) = 118.8477.

Mezzion Pharma Co Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201406 -2.639 99.353 -3.157
201409 171.828 99.608 205.017
201412 144.041 99.098 172.748
201503 469.173 99.720 559.167
201506 53.921 100.050 64.052
201509 64.570 100.110 76.656
201512 67.629 100.220 80.199
201603 49.188 100.560 58.133
201606 108.173 100.790 127.553
201609 59.018 101.460 69.132
201612 179.385 101.560 209.920
201703 60.041 102.850 69.380
201706 53.230 102.610 61.653
201709 49.314 103.490 56.632
201712 86.218 102.990 99.493
201803 220.837 104.100 252.123
201806 182.910 104.130 208.762
201809 494.215 105.650 555.952
201812 212.940 104.350 242.524
201903 188.913 104.490 214.871
201906 165.742 104.880 187.815
201909 164.138 105.200 185.432
201912 197.940 105.120 223.789
202003 195.308 105.540 219.935
202006 233.531 104.870 264.657
202009 258.741 106.200 289.555
202012 415.694 105.765 467.112
202103 221.297 107.357 244.983
202106 80.393 107.579 88.814
202109 88.184 108.759 96.364
202112 271.893 109.676 294.629
202203 83.167 111.806 88.405
202206 309.086 114.083 321.996
202209 256.359 114.831 265.326
202212 289.960 115.200 299.141
202303 289.955 116.550 295.672
202306 299.631 117.140 303.999
202309 285.475 119.111 284.843
202312 248.598 118.848 248.598
202403 72.877 118.848 72.877

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Mezzion Pharma Co  (XKRX:140410) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Mezzion Pharma Co Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Mezzion Pharma Co's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Mezzion Pharma Co (XKRX:140410) Business Description

Traded in Other Exchanges
N/A
Address
C&H, Samseong-dong, 154-8, Gangnam-gu, Dongdaemun-gu, Seoul, KOR, 135-879
Mezzion Pharma Co is a South Korea based drug manufacturer company. It develops and manufactures pharmaceutical products for erectile dysfunction and benign prostatic hyperplasia.

Mezzion Pharma Co (XKRX:140410) Headlines

No Headlines